Golden Biotechnology Corporation (TPEX:4132)
Taiwan
· Delayed Price · Currency is TWD 13.05
-0.90 (-6.45%)
Mar 9, 2026, 1:58 PM CST
Golden Biotechnology Company Description
Golden Biotechnology Corporation engages in research and development of new drug in Taiwan.
The company offers Antroquinonol for the treatment of pancreatic cancer, acute myeloid leukemia, blood diseases, non-small cell lung cancer, COVID-19, and other diseases.
It is also involved in development and sale of health foods and supplements, as well as provides products for oncology, infectious, and neurodegenerative diseases.
The company was founded in 2002 and is headquartered in New Taipei City, Taiwan.
Golden Biotechnology Corporation
| Country | Taiwan |
| Founded | 2002 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 116 |
| CEO | Li Yu Wu |
Contact Details
Address: No. 27-6, Zhongzheng East. Road New Taipei City, 251 Taiwan | |
| Phone | 886 2 2808 6006 |
| Website | goldenbiotech.com |
Stock Details
| Ticker Symbol | 4132 |
| Exchange | Taipei Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | TWD |
| ISIN Number | TW0004132006 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Li Yu Wu | President and Director |
| Jun Hua Lian | Treasurer |